Metagenomi

Metagenomi

Metagenomi

Metagenomi is a biotechnology company at the forefront of genetic engineering, striving to leverage microbial evolution to develop groundbreaking therapies for diseases. The company employs metagenomics, the study of genetic material recovered directly from natural environments, to discover and engineer a diverse toolbox of genome editing technologies. Their approach utilizes advanced techniques such as high-throughput screening and artificial intelligence to identify novel proteins capable of precise and efficient genomic modifications. These tools are designed for a wide array of applications, including programmable nucleases for gene modification, base editors for single nucleotide changes, and systems for large genomic alterations. Metagenomi's mission is to harness these next-generation technologies to create tailored, site-specific therapeutic interventions that address unmet medical needs, thus driving a transformative shift in medicine. By integrating their proprietary discovery platform and therapeutic focus, the company aims to establish new paradigms in the field of genetic medicine innovation.

Company details

5959 Horton St, Floor 7 , Emeryville , 94608 California, USA
View in map

Find locations served, office locations

Business Type:
Manufacturer
Industry Type:
Medical / Health Care
Market Focus:
Globally (various continents)

This company also provides solutions for other industrial applications.
Please, visit the following links for more info:

We harness the power of our proprietary metagenomics platform to create curative genetic medicines for patients

Our Origins
Our founders rec­og­nized the pow­er that nat­u­ral­ly evolved micro­bial sys­tems could have in rev­o­lu­tion­iz­ing access to enhanced genome edit­ing tech­nolo­gies to cre­ate poten­tial­ly high­ly effi­ca­cious and cura­tive genet­ic medicines

At Metageno­mi, we believe genome edit­ing tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to treat the vast major­i­ty of patients. Our goal is to unlock the full poten­tial of genome edit­ing by devel­op­ing tools with new capa­bil­i­ties using nov­el cel­lu­lar machin­ery dis­cov­ered from the nat­ur­al environment. 

Metageno­mi was found­ed by pio­neers in the field of metage­nomics. They rec­og­nized the pow­er that nat­u­ral­ly evolved micro­bial sys­tems could have in rev­o­lu­tion­iz­ing access to enhanced genome edit­ing tech­nolo­gies to cre­ate poten­tial­ly high­ly effi­ca­cious and cura­tive genet­ic med­i­cines. Our metage­nomics dis­cov­ery plat­form enables us to rapid­ly and effec­tive­ly find and engi­neer high­ly active nat­ur­al enzymes sourced from nature into genome edit­ing tools that are high­ly spe­cif­ic, effi­cient, and have enhanced targetability.

As the genet­ic med­i­cine field con­tin­ues to rapid­ly evolve, our plat­form posi­tions us to be at the fore­front of unlock­ing the full poten­tial of genome edit­ing through the con­tin­u­ous dis­cov­ery of new edit­ing sys­tems and the devel­op­ment of the next wave of genet­ic med­i­cines for patients.

Dri­ven by innovation

 We think outside the confines of what is 'known' or considered 'possible'. Our compounding sense of wonder and curiosity permeate the barriers of scientific discovery. We explore, question, and focus our efforts towards finding novel solutions to change the future of human health.

Ded­i­cat­ed to sci­en­tif­ic rigor

Our dedication to building a data-driven and scientifically rigorous enterprise supports our exploration of the unknown. We chart new paths of scientific inquiry with integrity and agility, learning as we go and pivoting when required. The quality of our work is what sets us apart — a product of our tenacity and drive for excellence.

Cham­pi­oned by each other

A supportive, inclusive environment of belonging gives rise to groundbreaking solutions. We hold space for each other, championing the wins and rebounding from the setbacks, together. We work towards our shared goal of developing curative therapeutics and strive for a profound impact on patient lives.